Patents by Inventor Stanley H. Pollock

Stanley H. Pollock has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7067155
    Abstract: The invention relates to an anti-inflammatory composition containing humate, such as insoluble, granular, other insoluble, or soluble humate, particularly Menefee Humate®. The invention also includes other anti-inflammatory compositions containing humate and at least one additional anti-inflammatory agent such as indomethacin or another nonsteroidal anti-inflammatory drug. The invention includes a method of treating acute or chronic inflammation in an animal, including a human, by administering one of these compositions. A method of facilitating the therapeutic effect of a therapeutic drug in an animal by co-administering humate is also provided.
    Type: Grant
    Filed: January 3, 2003
    Date of Patent: June 27, 2006
    Assignee: TBNI, Inc.
    Inventors: John F. Lown, Kevin Gill, Stephen J. Cutler, Horace G. Cutler, Stanley H. Pollock
  • Patent number: 6962899
    Abstract: Pharmaceutically acceptable compounds for administering to a subject, comprising the general structure II: wherein R1 is an L-amino acid or salt or ester thereof, or an L-amino acid containing peptide or salt or ester thereof; and wherein the stereochemistry about the carbon-carbon double bond is trans. The invention further relates to pharmaceutical compositions comprising the aforementioned compounds.
    Type: Grant
    Filed: December 4, 2002
    Date of Patent: November 8, 2005
    Assignees: Georgia Tech Research Corporation, Mercer University
    Inventors: Sheldon W. May, Stanley H. Pollock
  • Publication number: 20040131705
    Abstract: The invention relates to a novel anti-inflammatory composition containing humate, such as insoluble, granular, other insoluble, or soluble humate, particularly Menefee Humate®. The invention also includes other anti-inflammatory compositions containing humate and at least one additional anti-inflammatory agent such as indomethacin or another nonsteroidal anti-inflammatory drug. The invention includes a method of treating acute or chronic inflammation in an animal, including a human, by administering one of these compositions. A method of facilitating the therapeutic effect of a therapeutic drug in an animal by co-administering humate is also provided.
    Type: Application
    Filed: January 3, 2003
    Publication date: July 8, 2004
    Applicant: TBNI, Inc., a Texas Corporation
    Inventors: John F. Lown, Kevin Gill, Stephen J. Cutler, Horace G. Cutler, Stanley H. Pollock
  • Publication number: 20030153488
    Abstract: Pharmaceutically acceptable compounds for administering to a subject, comprising the general structure II: 1
    Type: Application
    Filed: December 4, 2002
    Publication date: August 14, 2003
    Applicant: Georgia Tech Research Corporation
    Inventors: Sheldon W. May, Stanley H. Pollock
  • Patent number: 6495514
    Abstract: The invention relates to a method for reducing inflammation in a subject by administering to the subject an effective amount of the compound having the structure I or II: wherein, R1 is C1-C10 branched or straight chain alkyl, aryl, an amino acid, or a peptide; and R2 is hydrogen or lower C1-C5 branched or straight alkyl, or the salt or ester thereof, wherein the stereochemistry about the carbon-carbon double bond is trans. The invention further relates to a method of inducing an analgesic effect by administering to a subject an effective amount of the compound having the structure I or II. The invention further relates to a compound having the structure II, wherein, R1 is an N-acyl amino acid or peptide, or the salt or ester thereof.
    Type: Grant
    Filed: January 21, 1998
    Date of Patent: December 17, 2002
    Assignee: Mercer University
    Inventors: Sheldon W. May, Stanley H. Pollock